Your browser doesn't support javascript.
loading
The safety and effectiveness of mirabegron in Parkinson's disease patients with overactive bladder: a randomized controlled trial.
Moussa, Mohamad; Chakra, Mohamad Abou; Dabboucy, Baraa; Fares, Youssef; Dellis, Athanasios; Papatsoris, Athanasios.
Affiliation
  • Moussa M; Urology Department, Zahraa Hospital, University Medical Center, Lebanese University, Beirut, Lebanon.
  • Chakra MA; Faculty of Medicine, Urology Department, Lebanese University, Beirut, Lebanon.
  • Dabboucy B; Department of Neurosurgery, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
  • Fares Y; Department of Neurosurgery, Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
  • Dellis A; Department of Urology/General Surgery, Areteion Hospital, Athens, Greece.
  • Papatsoris A; 2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Scand J Urol ; 56(1): 66-72, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34672847
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Urinary Bladder, Overactive / Urological Agents Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Journal: Scand J Urol Year: 2022 Document type: Article Affiliation country: Lebanon Country of publication: Sweden
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Urinary Bladder, Overactive / Urological Agents Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Journal: Scand J Urol Year: 2022 Document type: Article Affiliation country: Lebanon Country of publication: Sweden